Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
OpenAI’s measurement gaps are keeping ChatGPT ads budgets at test level
OpenAI’s ChatGPT ads have a measurement catch-22
In Graphic Detail: Where brands stand when AI agents do the shopping
Getting picked by the agents is the new commerce fight.
How Kroger, Giant Eagle and DoorDash are building their agentic AI assistants
Companies are finding that they must deploy practical AI tools that bridge the gap between physical stores and online ordering.